Jane Street Group, LLC Mei Pharma, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $0.35 $28,079 - $46,799	133,713 New	133,713 $30,000
Q3 2021 Nov 16, 2021	SELL	$2.52 - $2.99 $28,725 - $34,083	-11,399 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $3,406 - $4,781	1,310 Added 12.98%	11,399 $32,000
Q1 2021 May 18, 2021	BUY	$2.73 - $4.5 $27,542 - $45,400	10,089 New	10,089 $35,000
Q3 2020 Nov 17, 2020	SELL	$2.46 - $4.27 $28,700 - $49,818	-11,667 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$1.45 - $4.3 $17,507 - $51,918	-12,074 Reduced 50.86%	11,667 $48,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $17,805 - $60,539	23,741 New	23,741 $38,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $40,233 - $60,472	-24,384 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.48 - $2.52 $177,875 - $302,868	-120,186 Reduced 83.13%	24,384 $41,000
Q2 2019 Aug 15, 2019	BUY	$2.45 - $3.32 $354,196 - $479,972	144,570 New	144,570 $361,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.